ArticlePoultry science2026
Strain-specific responses of commercial broiler chickens to dietary supplementation of turnip leaf powder: Implications on growth performance, blood biochemistry and economic efficiency.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the differential implications of dietary supplementation with turnip leaf powder (TLP) on growth performance, immune function, hematological and biochemical profiles, as well as economic efficiency in two different broiler strains. A total of 320 10-day-old broiler chicks from two broiler strains (Avian 48 and Hubbard efficiency plus, 160 chicks/strain) were randomly assigned to a 2 × 4 factorial arrangement (TLP supplementation and broiler strain) forming eight treatments with four replicates each. TLP was supplemented at 0.0, 0.50, 1.00, and 1.50 g/kg of diet, over a 4-week experimental period. Avian-48 birds exhibited higher body weight and gain, and improved feed conversion ratio compared to Hubbard broilers in a linear pattern (P < 0.05). As the TLP supplementation level increased, dressing percentage increased, while gizzard relative weight declined linearly (P < 0.05). Improving growth and carcass yield, in response to TLP supplementation, were correlated with enhancement in digestive enzyme activities, reduction in coliform counts while modulating Lactobacillus populations in a strain-specific manner (P < 0.05). Moreover, immune and antioxidant status were improved, demonstrated by increased phagocytic activity and lymphocyte percentage, decreased heterophil percentage and MDA concentration, along with modulating total antioxidant capacity (P < 0.05). Hematological parameters, including PCV, hemoglobin, and RBC count, were improved with TLP supplementation, with hepatoprotective effects confirmed by reducing AST and ALT activities and normal hepatic morphology. In addition, serum lipid profiles showed favorable reductions in total cholesterol, triglycerides, and LDL in Hubbard broilers at higher TLP levels, whereas Avian 48 exhibited less consistent responses (P < 0.05). Most of these responses were significantly strain- dependent. Besides, the reported physiological improvements, in response to TLP supplementation, translated into significant economic benefits, evidenced by improving economic efficiency parameters and lowering the cost of feed/kg body weight gain. Collectively, TLP supplementation (1.0-1.5 g/kg diet, in Avian 48 and Hubbard, respectively) exerted various beneficial effects on growth performance, physiology, and economic performance, supporting its application as a natural feed additive, enhancing commercial broiler production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.